I

Immunis, Inc.

8 employees

Immunis a private biotechnology company developing a novel treatment for age and disease-related immune decline.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Date founded

2018

Funding rounds raised

Total raised

$10M

from 3 investors over 3 rounds

I

Immunis, Inc. raised $10M on August 3, 2022

Investors: Remiges Ventures, Inc. and Continuum Health Ventures

I

Immunis, Inc. raised undisclosed on January 1, 2020

Investors: Healthspan Capital

FAQ